Patients with ankylosing spondylitis and low disease activity because of anti-TNF-Alpha therapy have higher TRAIL levels than controls: A potential compensatory effect
- Genre, F.
- López-Mejías, R.
- Rueda-Gotor, J.
- Miranda-Filloy, J.A.
- Ubilla, B.
- Carnero-López, B.
- Palmou-Fontana, N.
- Gómez-Acebo, I.
- Blanco, R.
- Pina, T.
- Ochoa, R.
- González-Juanatey, C.
- Llorca, J.
- González-Gay, M.A.
Journal:
Mediators of Inflammation
ISSN: 1466-1861, 0962-9351
Year of publication: 2014
Volume: 2014
Type: Article